Merck (CGRP programme Rights) Overview
- Latest Deal Type
- Financing Rounds
Merck (CGRP programme Rights) General Information
Migraine drugs for treatment and prevention of migraines. The receptor antagonists and oral calcitonin gene-related peptide is used for treatment of migraines.
Corporate Backed or Acquired
Buildings and Property
Other Pharmaceuticals and Biotechnology
- Kenilworth, NJ
- United States
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
Merck (CGRP programme Rights) Valuation & Funding
Merck (CGRP programme Rights) Former Investors
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|